1Cell.Ai Named Best Healthtech Startup 2026
Recognised for Innovation in Precision Oncology & Patient Impact
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
In this insightful Expert Insights webinar, globally recognized precision oncology leader Dr. Razelle
Summary Circulating tumor cell (CTC) analysis demonstrated significant clinical relevance in treatment-naïve oral
Summary AI-enabled analysis of histopathology images demonstrated the ability to accurately predict homologous
Summary Clinical evaluation of circulating tumor cells (CTCs) in head and neck cancer
No publications found for this author yet.
PK
publications
RJ
publications
SI
publications
NA
publications
Discover evidence-driven publications, clinical perspectives, and scientific advances from the 1Cell.Ai team.